Literature DB >> 16446706

Lethal endotoxic shock using alpha-galactosylceramide sensitization as a new experimental model of septic shock.

Hiroyasu Ito1, Naoki Koide, Ferdaus Hassan, Shamima Islam, Gantsetseg Tumurkhuu, Isamu Mori, Tomoaki Yoshida, Shinichi Kakumu, Hisataka Moriwaki, Takashi Yokochi.   

Abstract

The effect of alpha-galactosylceramide (alpha-GalCer) on lipopolysaccharide (LPS)-mediated lethality was examined. Administration of LPS killed all mice pretreated with alpha-GalCer, but not untreated control mice. The lethal shock in alpha-GalCer-sensitized mice was accompanied by severe pulmonary lesions with marked infiltration of inflammatory cells and massive cell death. On the other hand, hepatic lesions were focal and mild. A number of cells in pulmonary and hepatic lesions underwent apoptotic cell death. alpha-GalCer sensitization was ineffective for the development of the systemic lethal shock in Valpha14-positive natural killer T cell-deficient mice. Sensitization with alpha-GalCer led to the circulation of a high level of interferon (IFN)-gamma and further augmented the production of tumor necrosis factor (TNF)-alpha in response to LPS. The lethal shock was abolished by the administration of anti-IFN-gamma or TNF-alpha antibody. Further, the lethal shock did not occur in TNF-alpha-deficient mice. Taken together, alpha-GalCer sensitization rendered mice very susceptible to LPS-mediated lethal shock, and IFN-gamma and TNF-alpha were found to play a critical role in the preparation and execution of the systemic lethal shock, respectively. The LPS-mediated lethal shock using alpha-GalCer sensitization might be useful for researchers employing experimental models of sepsis and septic shock.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16446706     DOI: 10.1038/labinvest.3700388

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  22 in total

1.  IL-15 Superagonist-Mediated Immunotoxicity: Role of NK Cells and IFN-γ.

Authors:  Yin Guo; Liming Luan; Whitney Rabacal; Julia K Bohannon; Benjamin A Fensterheim; Antonio Hernandez; Edward R Sherwood
Journal:  J Immunol       Date:  2015-07-27       Impact factor: 5.422

Review 2.  Innate T cells in the intensive care unit.

Authors:  Edy Yong Kim; William M Oldham
Journal:  Mol Immunol       Date:  2018-12-13       Impact factor: 4.407

3.  Endotoxin-induced lung injury in α-galactosylceramide-sensitized mice is caused by failure of interleukin-4 production in lung natural killer T cells.

Authors:  J Dagvadorj; G Tumurkhuu; Y Naiki; A S M Noman; I Iftakhar-E-Khuda; B Badamtseren; T Komatsu; N Koide; T Yoshida; T Yokochi
Journal:  Clin Exp Immunol       Date:  2010-08-19       Impact factor: 4.330

Review 4.  The biology of natural killer cells during sepsis.

Authors:  Yin Guo; Naeem K Patil; Liming Luan; Julia K Bohannon; Edward R Sherwood
Journal:  Immunology       Date:  2017-11-16       Impact factor: 7.397

Review 5.  NKT cells in sepsis.

Authors:  Briana Leung; Hobart W Harris
Journal:  Clin Dev Immunol       Date:  2010-10-04

6.  Coexpression of IL-18 strongly attenuates IL-12-induced systemic toxicity through a rapid induction of IL-10 without affecting its antitumor capacity.

Authors:  Maria Cecilia Rodriguez-Galan; Della Reynolds; Silvia G Correa; Pablo Iribarren; Morihiro Watanabe; Howard A Young
Journal:  J Immunol       Date:  2009-06-17       Impact factor: 5.422

Review 7.  Ceramide: a common pathway for atherosclerosis?

Authors:  Jean Bismuth; Peter Lin; Qizhi Yao; Changyi Chen
Journal:  Atherosclerosis       Date:  2007-10-25       Impact factor: 5.162

8.  A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice.

Authors:  B Arribas; M E Rodríguez-Cabezas; D Camuesco; M Comalada; E Bailón; P Utrilla; A Nieto; A Concha; A Zarzuelo; J Gálvez
Journal:  Br J Pharmacol       Date:  2009-05-26       Impact factor: 8.739

9.  Lipoteichoic acid synergizes with glycosphingolipids to potently stimulate secretion of interleukin-6 from human blood cells.

Authors:  Shiri Meron-Sudai; Ariella Matityahou; Yona Keisari; Kathleen H Cox; David L Hasty; Itzhak Ofek
Journal:  Clin Vaccine Immunol       Date:  2008-07-16

10.  The mechanism of development of acute lung injury in lethal endotoxic shock using alpha-galactosylceramide sensitization.

Authors:  G Tumurkhuu; N Koide; J Dagvadorj; A Morikawa; F Hassan; S Islam; Y Naiki; I Mori; T Yoshida; T Yokochi
Journal:  Clin Exp Immunol       Date:  2008-02-25       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.